VF
SGYP

Virtu Financial’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Virtu Financial’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-74,216
Closed -$126K – 2203
2018
Q3 		$126K Sell
74,216
-61,523
-45% -$110K 0.01% 1158
2018
Q2 		$236K Buy
135,739
+109,912
+426% +$190K 0.01% 1373
2018
Q1 		$47K Sell
25,827
-147,877
-85% -$312K ﹤0.01% 1730
2017
Q4 		$387K Buy
173,704
+144,768
+500% +$360K 0.02% 1050
2017
Q3 		$84K Buy
28,936
+17,106
+145% +$58.3K ﹤0.01% 2119
2017
Q2 		$53K Buy
+11,830
New +$48.8K 0.01% 366

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jefferies Group
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Virtu Financial's SGYP Position: Q4 2018 in Review

Virtu Financial sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 74,216 shares — an estimated $126K sold.

Virtu Financial first reported a position in SGYP in Q2 2017 and held it in 6 quarters. The position peaked at $387K in Q4 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Virtu Financial reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Virtu Financial sold 74,216 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $126K.
  • Virtu Financial first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 6 quarters.
  • Virtu Financial's Synergy Pharmaceuticals, Inc Common Stock position peaked at $387K in Q4 2017.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.